treat the patient as a whole, including obesity, insulin resistance, dyslipidemia, hypertension, and psychosocial disorders—all conditions frequently present in youth who have T2DM. Finally, as we gain more experience—both clinical and research—our approaches to some of these problems and recommendations may change over time. In addition to research, public health measures to increase activities of children and youth, along with public education campaigns for healthy eating may have a profound influence in curbing the epidemic of obesity and its related complications.


We are indebted to the children and their parents who participated in our research studies that facilitated our understanding of T2DM and related conditions.


[1] Fagot-Campagna A, Pettitt D, Engelgau MM, et al. Type 2 diabetes among North American children and adolescents: an epidemiologic review and a public health perspective. J Pediatr 2000;136(5):664-72.

[2] American Diabetes Association. Type 2 diabetes in children and adolescents. Diabetes Care 2000;23(3):381-9.

[3] Ehtisham S, Barrett TG, Shaw NJ. Type 2 diabetes mellitus in UK children: an emerging problem. Diabet Med 2000;17(12):867-71.

[4] Ehtisham S, Kirk J, McEvilly A, et al. Prevalence of type 2 diabetes in children in Birmingham. BMJ 2001;322(7299):1428.

[5] Ehtisham S, Hattersley AT, Dunger DB, et al, British Society for Paediatric Endocrinology and Diabetes Clinical Trials Group. First UK survey of paediatric type 2 diabetes and MODY. Arch Dis Child 2004;89(6):526-9.

[6] Ortega-Rodriguez E, Levy-Marchal C, Tubiana N, et al. Emergence of type 2 diabetes in an hospital based cohort of children with diabetes mellitus. Diabetes Metab 2001;27(1):574-8.

[7] Drake AJ, Smith A, Betts PR, et al. Type 2 diabetes in obese white children. Arch Dis Child 2002;86(3):207-8.

[8] Holl RW, Grabert M, Krause U, et al. Prevalence and clinical characteristics of patients with non-type 1 diabetes in the pediatric age range: analysis of a multicenter database including 20,410 patients from 148 center in Germany and Austria. Diabetologia 2003;46(Suppl 2):A26.

[9] Rami B, Schober E, Nachbauer E, et al, Austrian Diabetes Incidence Study Group. Type 2 diabetes mellitus is rare but not absent in children under 15 years of age in Austria. Eur J Pediatr 2003;162(12):850-2.

[10] Zachrisson I, Tibell C, Bang P, et al. Prevalence of type 2 diabetes among known cases of diabetes aged 0-18 years in Sweden. Diabetologia 2003;46(Suppl 2):A25.

[11] Chan JC, Hawkins BR, Cockram CS. A Chinese family with non-insulin-dependent diabetes of early onset and severe diabetic complications. Diabet Med 1990;7(3):211 -4.

[12] Kitagawa T, Owada M, Urakami T, et al. Epidemiology of type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetes mellitus in Japanese children. Diabetes Res Clin Pract 1994;24(Suppl 1):S7-13.

[13] Kitagawa T, Owada M, Urakami T, et al. Increased incidence of non-insulin dependent diabetes mellitus among Japanese school children correlates with an increased intake of animal protein and fat. Clin Pediatr 1998;37(2):111-5.

[14] Tajima N. Type 2 diabetes in children and adolescents in Japan. International Diabetes Monitor 2002;14:1-5.

[15] Wei JN, Sung FC, Lin CC, et al. National surveillance for type 2 diabetes mellitus in Taiwanese children. JAMA 2003;290(10):1345-50.

[16] Kadiki O, Reddy M, Marzouk A. Incidence of insulin-dependent diabetes (IDDM) and non insulin-dependent diabetes (NIDDM) (0-34 years at onset) in Benghazi, Libya. Diabetes Res Clin Pract 1996;32(3):165-73.

[17] Braun B, Zimmermann MB, Kretchmer N, et al. Risk factors for diabetes and cardiovascular disease in young Australian aborigines: a 5-year follow-up study. Diabetes Care 1996;19(5): 472-9.

[18] Saad MF, Knowler WC, Pettitt DJ, et al. A two-step model for development of non-insulin-dependent diabetes. Am J Med 1991;90(2):229-35.

[19] Gungor N, Bacha F, Saad R, et al. Youth type 2 diabetes: insulin resistance, beta-cell failure, or both? Diabetes Care 2005;28(3):638-44.

[20] Reisman D. Mild diabetes in children. Am J Med Sci 1916;151:40-5.

[21] Savage PJ, Bennett PH, Senter RG, et al. High prevalence of diabetes in young Pima Indians: evidence of phenotypic variation in a genetically isolated population. Diabetes 1979;28(10): 937-42.

[22] Freedman D, Serdula M, Percy C, et al. Obesity, levels of lipids and glucose and smoking among Navajo adolescents. J Nutr 1997;127(Suppl 10):2120-7.

[23] Dabelea D, Hanson RL, Bennett PH, et al. Increasing prevalence oftype 2 diabetes in American Indian children. Diabetologia 1998;41(8):904-10.

[24] Moore KR, Harwell TS, McDowall JM, et al. Three-year prevalence and incidence of diabetes among American Indian youth in Montana and Wyoming, 1999 to 2001. J Pediatr 2003;143(3): 368-71.

[25] Acton KJ, Burrows NR, Moore K, et al. Trends in diabetes prevalence among American Indian and Alaska native children, adolescents, and young adults. Am J Public Health 2002;92(9): 1485-90.

[26] Dean HJ, Young TK, Flett B, et al. Screening of non-type 2 diabetes in aboriginal children in northern Canada [letter]. Lancet 1998;352(9139):1523-4.

[27] Huen KF, Low LC, Wong GW, et al. Epidemiology of diabetes mellitus in children in Hong Kong: the Hong Kong childhood diabetes register. J Pediatr Endocrinol Metab 2000;13(3): 297-302.

[28] Jung-Nan W, Fung-Chang S, Chau-Ching L, et al. National surveillance for type 2 diabetes mellitus in Taiwanese children. JAMA 2003;290(10):1345-50.

[29] Libman IM, LaPorte RE, Becker D, et al. Was there an epidemic of diabetes in nonwhite adolescents in Allegheny County, Pennsylvania? Diabetes Care 1998;21(8):1278-81.

[30] Libman IM, Pietropaolo M, Trucco M, et al. Islet cell autoimmunity in white and black children and adolescents with IDDM. Diabetes Care 1998;21(11):1824-7.

[31] Libman IM, Pietropaolo M, Arslanian SA, et al. Evidence for heterogeneous pathogenesis of insulin-treated diabetes in black and white children. Diabetes Care 2003;26(10):2876-82.

[32] Pinhas-Hamiel O, Dolan LM, Daniels SR, et al. Increased incidence of non-insulin dependent diabetes mellitus among adolescents. J Pediatr 1996;128(5):608-15.

[33] Scott C, Smith J, Cradock M, et al. Characteristics of youth-onset non-insulin dependent diabetes mellitus and insulin-dependent diabetes mellitus at diagnosis. Pediatrics 1997;100(1):84-91.

[34] Willi SM, Kennedy A, Wojciechowski B, et al. Insulin resistance and defective glucose-insulin coupling in ketosis-prone type 2 diabetes of African-American youth. Diabetes 1998; 47(Suppl 1):A306.

[35] Glaser NS, Jones KL. Non-insulin dependent diabetes mellitus in Mexican-American children. West J Med 1998;168(1):11-6.

[36] Neufeld N, Raffel L, Landon C, et al. Early presentation of type 2 diabetes in Mexican-American youth. Diabetes Care 1998;21(1):80-6.

[37] Hale DE, Danney KM. Non-insulin dependent diabetes in Hispanic youth (type 2Y). Diabetes 1998;47(Suppl 1):A82.

Silverstein JH, Rosenbloom AL. Treatment of type 2 diabetes mellitus in children and adolescents. J Pediatr Endocrinol Metab 2000;13(Suppl 6):1403-9.

Likitmaskul S, Kiattisathavee P, Chaichan-Watanakul K, et al. Increasing prevalence of type 2 diabetes mellitus in Thai children and adolescents associated with increasing prevalence of obesity. J Pediatr Endocrinol Metab 2003;16(1):71-7.

Kahn SE. Regulation of ß-cell function in vivo: from health to disease. Diabetes Reviews 1996;4:372-89.

Kahn SE. The importance of ß-cell failure in the development and progression of type 2 diabetes. J Clin Endocrinol Metab 2001;86(9):4047-58.

Stumvoll M, Goldstein B, van Haeften TW. Type 2 diabetes: principles of pathogenesis and therapy. Lancet 2005;365(9467):1333-46.

Himsworth H. Diabetes mellitus: a differentiation into insulin-sensitive and insulin-insensitive types. Lancet 1936;i:127-30.

Reaven GM. Role of insulin resistance in the pathophysiology of non-insulin dependent diabetes mellitus. Diabetes Metab Rev 1993;9(Suppl 1):5S-12S.

Weyer C, Bogardus C, Mott DM, et al. The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. J Clin Invest 1999;104(6): 787-94.

Banerji MA, Lebovitz HE. Insulin action in black Americans with NIDDM. Diabetes Care 1992;15(10):1295-302.

Umpaichitra V, Bastian W, Taha D, et al. C-peptide and glucagon profiles in minority children with type 2 diabetes mellitus. J Clin Endocrinol Metab 2001;86(4):1605-9.

Kobayashi K, Amemiya S, Higashida K, et al. Pathogenic factors of glucose intolerance in obese Japanese adolescents with type 2 diabetes. Metabolism 2000;49(2):186-91.

Roder ME, Dinesen B, Hartling SG, et al. Intact proinsulin and ß-cell function in lean and obese subjects with and without type 2 diabetes. Diabetes Care 1999;22(4):609-14.

Arslanian SA. Type 2 diabetes mellitus in children: clinical aspects and risk factors. Horm

Res 2002;57(Suppl 1):19-28.

Tripathy D, Carlsson M, Almgren P, et al. Insulin secretion and insulin sensitivity in relation to glucose tolerance: lessons from the Botnia study. Diabetes 2000;49(6):975-80. Matthews DR, Cull CA, Stratton IM, et al. UKPDS 26: sulfonylurea failure in non-insulin dependent diabetic patients over six years. Diabet Med 1998;15(4):297-303. Holman RR. Assessing the potential for alpha-glucosidase inhibitors in prediabetic states. Diabetes Res Clin Pract 1998;40(Suppl):S21-5.

Levy J, Atkinson AB, Bell PM, et al. Beta-cell deterioration determines the onset and rate of progression of secondary dietary failure in type 2 diabetes mellitus: the 10-year follow-up of the Belfast Diet Study. Diabet Med 1998;15(4):290-6.

Gungor N, Arslanian S. Progressive beta cell failure in type 2 diabetes mellitus of youth. J Pediatr 2004;144(5):656-9.

Kahn CR. Banting lecture: insulin action, diabetogenes, and the cause of type II diabetes. Diabetes 1994;43(8):1066-84.

Hansen L, Pedersen O. Genetics of type 2 diabetes mellitus: status and perspectives. Diabetes Obes Metab 2005;7(2):122-35.

Poulsen P, Kyvik KO, Vaag A, et al. Heritability of type II (non-insulin-dependent) diabetes mellitus and abnormal glucose tolerance: a population-based twin study. Diabetologia 1999; 42(2):139-45.

Medici F, Hawa M, Ianari A, et al. Concordance rate for type II diabetes mellitus in monozygotic twins: actuarial analysis. Diabetologia 1999;42(2):146-50. Zimmet P, Turner R, McCarty D, et al. Crucial points at diagnosis: type 2 diabetes or slow type 1 diabetes. Diabetes Care 1999;22(Suppl 2):B59-64.

Martin BC, Warram JH, Krolewski AS, et al. Role of glucose and insulin resistance in development of type 2 diabetes mellitus: results of a 25-year follow up study. Lancet 1992; 340(8825):925-9.

Goldfine AB, Bouche C, Parker RA, et al. Insulin resistance is a poor predictor of type 2

diabetes in individuals with no family history of disease. Proc Natl Acad Sci USA 2003; 100(5):2724-9.

[63] Lillioja S, Mott DM, Spraul M, et al. Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus: prospective studies of Pima Indians. N Engl J Med 1993;329(27):1988-92.

[64] Elbein SC, Hasstedt SJ, Wegner K, et al. Heritability of pancreatic ß-cell function among nondiabetic members of Caucasian familial type 2 diabetic kindreds. J Clin Endocrinol Metab 1999;84(4):1398-403.

[65] Danadian K, Balasekaren G, Lewy V, et al. Insulin sensitivity in African-American children with and without family history of type 2 diabetes. Diabetes Care 1999;22(8):1325-9.

[66] Arslanian SA, Bacha F, Saad R, et al. Family history of type 2 diabetes is associated with decreased insulin sensitivity and an impaired balance between insulin sensitivity and insulin secretion in white youth. Diabetes Care 2005;28(1):115-9.

[67] Rosenbloom AL, Joe JR, Young RS, et al. Emerging epidemic of type 2 diabetes in youth. Diabetes Care 1999;22(2):345-54.

[68] Dietz WD, Robinson TN. Overweight children and adolescents. N Engl J Med 2005;352(20): 2100-9.

[69] Ogden C, Flegal K, Carroll M, et al. Prevalence and trends in overweight among US children and adolescents, 1999-2000. JAMA 2002;288(14):1728-32.

[70] Ludwig DS, Peterson KE, Gortmaker SL. Relation between consumption of sugar-sweetened drinks and childhood obesity: a prospective observational analysis. Lancet 2001;357(9255): 505-8.

[71] Morton JF, Guthrie JF. Changes in children's total fat intakes and their food group sources of fat, 1989-91 versus 1994-95: implications for diet quality. Family Economics and Nutrition Review 1998;11:44-57.

[72] Kimm SY, Glynn NW, Kriska AM, et al. Longitudinal changes in physical activity in a biracial cohort during adolescence. Med Sci Sports Exerc 2000;32(8):1445-54.

[73] Andersen RE, Crespo CJ, Bartlett SJ, et al. Relationship of physical activity and television watching with body weight and level of fatness among children: results from the third National Health and Nutrition Examination Survey. JAMA 1998;279(12):938-42.

[74] Sorensen TIA. The changing lifestyle in the world: body weight and what else? Diabetes Care 2000;23:B1 -4.

[75] Hill JO, Peters JC. Environmental contributions to the obesity epidemic. Science 1998; 280(5368):1371 -4.

[76] Arslanian S, Danadian K. Insulin secretion, insulin sensitivity and diabetes in black children. Trends Endocrinol Metab 1998;9:194-9.

[77] Caprio S, Tamborlane WV. Metabolic impact of obesity in childhood. Endocrinol Metab Clin North Am 1999;28(4):731-47.

[78] Bacha F, Saad R, Gungor N, et al. Adiponectin in youth: relationship to visceral adiposity, insulin sensitivity, and beta-cell function. Diabetes Care 2004;27(2):547-52.

[79] Weyer C, Funahashi T, Tanaka S, et al. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 2001; 86(5):1930-5.

[80] Gower BA, Nagy TR, Goran MI. Visceral fat, insulin sensitivity and lipids in prepubertal children. Diabetes 1999;48(8):1515-21.

[81] Bacha F, Saad R, Gungor N, et al. Obesity, regional fat distribution and syndrome X in obese black vs white adolescents: race differential in diabetogenic and atherogenic risk factors. J Clin Endocrinol Metab 2003;88(6):2534-40.

[82] Kissebah AH. Central obesity: measurement and metabolic effects. Diabetes Review 1997;5:8-20.

[83] Weiss R, Dufour S, Taksali SE, et al. Prediabetes in obese youth: a syndrome of impaired glucose tolerance, severe insulin resistance, and altered myocellular and abdominal fat partitioning. Lancet 2003;362(9388):951 -7.

[84] Dean H. NIDDM-Y in first nation children in Canada. Clin Pediatr 1998;37(2):89-96.



Dabelea D, Pettitt DJ, Jones KL, et al. Type 2 diabetes mellitus in minority children and adolescents: an emerging problem. Endocrinol Metab Clin North Am 1999;28(4):709-29. Knowler WC, Pettitt DJ, Saad MF. Diabetes mellitus in the Pima Indians: incidence, risk factors and pathogenesis. Diabetes Metab Rev 1990;6(1):1 -27.

Svec F, Nastasi K, Hilton C, et al. Black-white contrasts in insulin levels during pubertal development: the Bogalusa Heart Study. Diabetes 1992;41(3):313-7.

Arslanian S, Suprasongsin C. Differences in the in vivo insulin secretion and sensitivity in healthy black vs white adolescents. J Pediatr 1996;129(3):440-4.

Arslanian S, Suprasongsin C. Testosterone treatment in adolescents with delayed puberty: changes in body composition, protein, fat and glucose metabolism. J Clin Endocrinol Metab 1997;82(10):3213-20.

Arslanian SA, Saad R, Lewy V, et al. Hyperinsulinemia in African-American children: decreased insulin clearance and increased insulin secretion and its relationship to insulin sensitivity. Diabetes 2002;51(10):3014-9.

Gower BA, Fernandez JR, Beasley TM, et al. Using genetic admixture to explain racial differences in insulin-related phenotypes. Diabetes 2003;52(4):1047-51.

Bacha F, Saad R, Gungor N, et al. Does adiponectin explain the lower insulin sensitivity and hyperinsulinemia of African-American children? Pediatr Diabetes 2005;6(2):100-2.

Goran MI, Bergman RN, Cruz ML, et al. Insulin resistance and associated compensatory responses in African American and Hispanic children. Diabetes Care 2002;25(12):2184-90.

Lestradet H, Deschamps I, Giron B. Insulin and free fatty acid levels during oral glucose tolerance tests and their relation to age in 70 healthy children. Diabetes 1976;25(6):505-8.

Smith CP, Williams AJ, Thomas JM, et al. The pattern of basal and stimulated insulin responses to intravenous glucose in first degree relatives of type 1 (insulin-dependent) diabetic children and unrelated adults aged 5 to 50 years. Diabetologia 1988;31(7):430-4.

Amiel SA, Caprio S, Sherwin RS, et al. Insulin resistance of puberty: a defect restricted to peripheral glucose metabolism. J Clin Endocrinol Metab 1991;72(2):277-82.

Bloch CA, Clemons P, Sperling MA. Puberty decreases insulin sensitivity. J Pediatr 1987;

Arslanian SA, Kalhan SC. Correlations between fatty acid and glucose metabolism: potential explanation of insulin resistance of puberty. Diabetes 1994;43(7):908-14.

Caprio S, Plewe G, Diamond MP, et al. Increased insulin secretion in puberty: a compensatory response to reductions in insulin sensitivity. J Pediatr 1989;114(6):963-7.

Saad RJ, Keenan BS, Danadian K, et al. Dihydrotestosterone treatment in adolescents with delayed puberty: does it explain insulin resistance of puberty? J Clin Endocrinol Metab 2001;

Dunaif A. Insulin action in the polycystic ovary syndrome. Endocrinol Metab Clin North Am 1999;28(2):341 -59.

Arslanian SA, Witchel SF. Polycystic ovary syndrome in adolescents: is there an epidemic? Current Opinion in Endocrinology and Diabetes 2002;9:32-42.

Legro RS, Kunselman AR, Dodson WC, et al. Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women. J Clin Endocrinol Metab 1999;84(1):165-9. Ehrmann DA. Polycystic ovary syndrome. N Engl J Med 2005;352(12):1223-36. Palmert MR, Gordon CM, Kartashov AI, et al. Screening for abnormal glucose tolerance in adolescents with polycystic ovary syndrome. J Clin Endocrinol Metab 2002;87(3):1017-23. Lewy VD, Danadian K, Witchel SF, et al. Early metabolic abnormalities in adolescent girls with polycystic ovarian syndrome. J Pediatr 2001;138(1):38-44.

Arslanian SA, Lewy VD, Danadian K. Glucose intolerance in obese adolescents with polycystic ovary syndrome: roles of insulin resistance and beta-cell dysfunction and risk of cardiovascular disease. J Clin Endocrinol Metab 2001;86(1):66-71.

Stuart CA, Gilkison CR, Smith MM, et al. Acanthosis nigricans as a risk factor for non-insulin dependent diabetes mellitus. Clin Pediatr 1998;37(2):73-9.

5 Easy Rules for Hard Abs

5 Easy Rules for Hard Abs

Ask the average guy to tell you how to get rock-hard abs and he will boast about the newest and fanciest, super-duper

Get My Free Ebook

Post a comment